Harpoon Therapeutics Financials
HARPDelisted Stock | USD 0.85 0.00 0.00% |
Harpoon |
Understanding current and past Harpoon Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Harpoon Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Harpoon Therapeutics' assets may result in an increase in income on the income statement.
Harpoon Therapeutics Stock Summary
Harpoon Therapeutics competes with Passage Bio, Black Diamond, Alector, Stoke Therapeutics, and Adaptimmune Therapeutics. Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the bodys immune system to treat patients suffering from cancer and other diseases in the United States. Harpoon Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Harpoon Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US41358P1066 |
Business Address | 131 Oyster Point |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.harpoontx.com |
Phone | 650 443 7400 |
Currency | USD - US Dollar |
Harpoon Therapeutics Key Financial Ratios
Harpoon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Harpoon Therapeutics's current stock value. Our valuation model uses many indicators to compare Harpoon Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Harpoon Therapeutics competition to find correlations between indicators driving Harpoon Therapeutics's intrinsic value. More Info.Harpoon Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Harpoon Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Harpoon Therapeutics Market Pulse
Quote | 0.85 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 0.85 |
Low | 0.82 |
High | 0.86 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Harpoon Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Harpoon has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Harpoon Therapeutics' financials are consistent with your investment objective using the following steps:- Review Harpoon Therapeutics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Harpoon Therapeutics' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Harpoon Therapeutics' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Harpoon Therapeutics' stock is overvalued or undervalued.
Harpoon Therapeutics November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Harpoon Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Harpoon Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Harpoon Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Harpoon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Harpoon Therapeutics's daily price indicators and compare them against related drivers.
Downside Deviation | 3.98 | |||
Information Ratio | 0.0952 | |||
Maximum Drawdown | 22.48 | |||
Value At Risk | (6.25) | |||
Potential Upside | 9.59 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Harpoon Stock
If you are still planning to invest in Harpoon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Harpoon Therapeutics' history and understand the potential risks before investing.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |